These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11654243)
21. Chakrabarty: tempest in a test tube. Green HP Hastings Cent Rep; 1980 Oct; 10(5):12-3. PubMed ID: 11643615 [No Abstract] [Full Text] [Related]
22. Designer genes that don't fit: a tort regime for commercial releases of genetic engineering products. Harv Law Rev; 1987 Mar; 100(5):1086-105. PubMed ID: 11658845 [No Abstract] [Full Text] [Related]
23. Abortion policy in the post-Webster age. Halva-Neubauer G Publius; 1990; 20(3):27-44. PubMed ID: 11656128 [No Abstract] [Full Text] [Related]
24. U.S. compromises on genetic engineering controls. New Sci; 1981 Apr; 90(1251):268. PubMed ID: 11664139 [No Abstract] [Full Text] [Related]
25. You shall be as gods. Powledge TM Worldview; 1977 Sep; 20(9):45-7. PubMed ID: 11661489 [No Abstract] [Full Text] [Related]
26. The emerging federalism of U.S. biotechnology policy. Webber DJ Politics Life Sci; 1995 Feb; 14(1):65-72. PubMed ID: 11654872 [No Abstract] [Full Text] [Related]
27. Patenting biology: DNA and oil-eaters. Sci News; 1978 Mar; 113(11):167+. PubMed ID: 11661560 [No Abstract] [Full Text] [Related]
28. Special informed consent requirements are included in protocol review procedures. Maloney DM Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274 [No Abstract] [Full Text] [Related]
29. AIDS in the workplace: public and corporate policy. Heacock MV; Orvis GP Harv J Law Public Policy; 1990; 13(2):689-713. PubMed ID: 11656268 [No Abstract] [Full Text] [Related]
30. Development of vaccines to meet public health needs: incentives and obstacles. Russell PK Risk; 1996; 7(3):239-52. PubMed ID: 11655077 [No Abstract] [Full Text] [Related]
32. An historical development of patenting microorganisms and genetically engineered animals in the USA and Europe. McTaggart RJ Eur J Genet Soc; 1996; 2(1):2-14. PubMed ID: 11658254 [No Abstract] [Full Text] [Related]
33. Toward a more perfect union: a federal cause of action for physician aid-in-dying. Robichaud TD Univ Mich J Law Reform; 1994; 27(2):521-64. PubMed ID: 11656405 [No Abstract] [Full Text] [Related]
36. Research on recombinant DNA molecules: the regulatory issues. Hutt PB South Calif Law Rev; 1978 Sep; 51(6):1435-50. PubMed ID: 11661661 [No Abstract] [Full Text] [Related]
37. Recombinant DNA pioneers lower the alarm. Norman C Sci Gov Rep; 1977 Jul; 7(12):1-3. PubMed ID: 11661486 [No Abstract] [Full Text] [Related]
38. Human cloning and the law. Newman SA J Biolaw Bus; 1998; 1(3):59-62. PubMed ID: 11657282 [No Abstract] [Full Text] [Related]
39. RU 486 and the politics of drug regulation in the United States and France. Kramnick RK Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340 [No Abstract] [Full Text] [Related]